Renergen's revenue for the
six
months ended in Aug. 2024 was A$2.13 Mil.
Its revenue for the trailing twelve months (TTM) ended in Aug. 2024 was A$2.55 Mil.
Renergen's Revenue per Share for the
six
months ended in Aug. 2024 was A$0.01.
Its Revenue per Share for the trailing twelve months (TTM) ended in Aug. 2024 was A$0.02.
Warning Sign:
Renergen Ltd revenue per share is in decline over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Renergen was -15.70% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 130.90% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 45.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 8 years, Renergen's highest 3-Year average Revenue per Share Growth Rate was 130.90% per year. The lowest was -23.70% per year. And the median was 4.60% per year.
Renergen Revenue Historical Data
The historical data trend for Renergen's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Oil & Gas E&P subindustry, Renergen's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Renergen's Revenue Distribution in the Oil & Gas Industry
For the Oil & Gas industry and Energy sector, Renergen's Revenue distribution charts can be found below:
* The bar in red indicates where Renergen's Revenue falls into.
Renergen Revenue Calculation
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Aug. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$2.55 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Renergen (ASX:RLT) Revenue Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Renergen Revenue Related Terms
Thank you for viewing the detailed overview of Renergen's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Renergen Ltd is an investment holding company focused on the alternative and renewable energy sectors in South Africa and sub-Saharan Africa. Its reportable segments are the Corporate Head office where all investment decisions are made; Tetra4 which explores, produces, and sells LNG in South Africa; Cryovation which has developed Cryo-VaccTM technology, and enables the safe transportation of vaccines and biologics at extremely low temperatures without the need for electrical power; and the Renergen U.S segment which assists with various fundraising and business development activities of the Group in the U.S market. The majority of the company's revenue is generated from the Tetra4 segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ASX:RLT has been successfully added to your 